 Connection
Michael Clay to Diagnosis, Differential
This is a "connection" page, showing publications Michael Clay has written about Diagnosis, Differential.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.398 |
|
|
|
-
Clay MR, Patel A, Tran Q, Hedges DJ, Chang TC, Stewart E, Charville G, Cline C, Dyer MA, Orr BA. Methylation profiling reveals novel molecular classes of rhabdomyosarcoma. Sci Rep. 2021 11 15; 11(1):22213.
Score: 0.147
-
Clay MR, Martinez AP, Weiss SW, Edgar MA. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective. Am J Surg Pathol. 2016 12; 40(12):1647-1652.
Score: 0.104
-
Clay MR, Martinez AP, Weiss SW, Edgar MA. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria. Am J Surg Pathol. 2015 Oct; 39(10):1433-9.
Score: 0.096
-
Santiago T, Clay MR, Allen SJ, Orr BA. Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma. Mod Pathol. 2017 06; 30(6):884-891.
Score: 0.026
-
Steen AJ, Shin JH, Pace NC, Edgar M, Clay MR, Linos K, Barton DT, Mann JA. Bullous Kaposiform Hemangioendothelioma Masquerading as Aplasia Cutis Congenita. Pediatr Dermatol. 2016 Sep; 33(5):e267-9.
Score: 0.025
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|